Imaging of CDH17-positive gastric cancer xenografts with 64Cu-labeled anti-CDH17 IgG PET

被引：0
|
作者：
Fujiwara, K. [1 ]
Koyama, K. [1 ]
Suga, K. [2 ]
Takahashi, M. [1 ]
Kusano-Arai, O. [3 ]
Mitsui, K. [3 ]
Akiba, H. [4 ]
Iwanari, H. [3 ]
Tsumoto, K. [4 ]
Hamakubo, T. [3 ]
Momose, T. [1 ]
机构：
[1] Univ Tokyo, Grad Sch Med, Dept Radiol, Tokyo, Japan
[2] SANKYO LABO SERV Co Ltd, Tokyo, Japan
[3] Univ Tokyo, Res Ctr Adv Sci & Technol, Dept Quantitat Biol & Med, Tokyo, Japan
[4] Univ Tokyo, Sch Engn, Dept Bioengn, Tokyo, Japan
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2015年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
P166
引用
收藏
页码：S420 / S420
页数：1
相关论文
共 50 条
  • [1] 64Cu-labeled minibody D2101 visualizes CDH17-positive gastric cancer xenografts with short waiting time
    Fujiwara, Kentaro
    Akiba, Hiroki
    Tsuji, Atsushi B.
    Sudo, Hitomi
    Sugyo, Aya
    Nagatsu, Kotaro
    Zhang, Ming-Rong
    Iwanari, Hiroko
    Kusano-Arai, Osamu
    Kudo, Shota
    Kikuchi, Chika
    Tsumoto, Kouhei
    Momose, Toshimitsu
    Hamakubo, Takao
    Higashi, Tatsuya
    NUCLEAR MEDICINE COMMUNICATIONS, 2020, 41 (07) : 688 - 695
  • [2] Biodistirbution study of 111In-anti-CDH17 minibody using CDH17-positive gastric cancer xenograft mice
    Fujiwara, K.
    Koyama, K.
    Akiba, H.
    Iwanari, H.
    Higashi, T.
    Tsumoto, K.
    Hamakubo, T.
    Momose, T.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S556 - S557
  • [3] The diagnostic significance of CDH17-positive circulating tumor cells in patients with colorectal cancer
    Pei, Xiao Meng
    Wong, Heong Ting
    Ng, Simon Siu Man
    Leung, Wing Wa
    Wong, Yee Ni
    Tsang, Hin Fung
    Chan, Amanda Kit Ching
    Wong, Yin Kwan Evelyn
    Yu, Allen Chi Shing
    Yim, Aldrin Kay Yuen
    Cho, William Chi Shing
    Chan, John Kwok Cheung
    Wong, Kwong Fai
    Luk, John M.
    Tai, William Chi Shing
    Wong, Sze Chuen Cesar
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2023, 23 (02) : 171 - 179
  • [4] Development and Characterization of the [177Lu]Lu-Labeled Anti-CDH17 Nanobody Derivative for Radioimmunotherapy in the Gastric Cancer Xenograft Model
    Mao, Chenkai
    Li, Shicheng
    Fan, Rencai
    Zhang, Jiaqi
    Fan, Xinying
    Shentu, Zhen
    Zhuang, Zhixiang
    Gan, Lei
    MOLECULAR PHARMACEUTICS, 2025, 22 (04) : 2077 - 2087
  • [5] PET Imaging of human Glioblastoma and Colorectal Cancer Xenografts Using 64Cu-Labeled D114 Antibody
    Zhou, Bin
    Wang, Hui
    Liu, Ren
    Wang, Mengzhe
    Deng, Huaifu
    Giglio, Ben
    Gill, Parkash
    Shan, Hong
    Li, Zibo
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [6] Preclinical evaluation of a 64Cu-labeled disintegrin for PET imaging of prostate cancer
    Hossein Jadvar
    Kai Chen
    Ryan Park
    Li-Peng Yap
    Ivetta Vorobyova
    Steve Swenson
    Francis S. Markland
    Amino Acids, 2019, 51 : 1569 - 1575
  • [7] Preclinical evaluation of a 64Cu-labeled disintegrin for PET imaging of prostate cancer
    Jadvar, Hossein
    Chen, Kai
    Park, Ryan
    Yap, Li-Peng
    Vorobyova, Ivetta
    Swenson, Steve
    Markland, Francis S.
    AMINO ACIDS, 2019, 51 (10-12) : 1569 - 1575
  • [8] BI 905711, a novel CDH17-targeting TRAILR2 agonist, effectively triggers tumor cell apoptosis and tumor regressions selectively in CDH17-positive colorectal cancer models
    Garcia-Martinez, Juan Manuel
    Wernitznig, Andreas
    Rinnenthal, Joerg
    Impagnatiello, Maria Antonietta
    Hilberg, Frank
    Giragossian, Craig
    Kraut, Norbert
    Pearson, Mark
    Kuenkele, Klaus-Peter
    CANCER RESEARCH, 2019, 79 (13)
  • [9] 64Cu-Labeled Folate Radioconjugate for PET Imaging of Folate Receptor-Positive Tumors
    Farkas, R.
    Siwowska, K.
    van der Meulen, N. P.
    Schibli, R.
    Mueller, C.
    RADIOTHERAPY AND ONCOLOGY, 2016, 118 : S40 - S40
  • [10] 64Cu-labeled TCP-1 probe for PET imaging of colorectal cancer
    Li, Feng
    Yang, Zhen
    Chen, Jiexiao
    Gray, Brian
    Pak, Chris
    Martin, Diego
    Liu, Zhonglin
    NUCLEAR MEDICINE AND BIOLOGY, 2023, 126 : S254 - S254
12345